Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
OsteosarcomaLeukemiaLymphoma
Interventions
DRUG

glucarpidase, high-dose methotrexate, leucovorin

single intravenous dose

DRUG

high-dose methotrexate, leucovorin

standard of care, leucovorin every 6 hours

Trial Locations (25)

19104

Children's Hospital of Philadelphia, Philadelphia

27834

ECU Brody School of Medicine, Greenville

33607

St. Joseph's Hospital, Tampa

38105

St. Jude Children's Research Hospital, Memphis

39216

University of MS Medical Center, Jackson

40536

University of Kentucky, Lexington

44718

Gabrail Cancer Center, Canton

46202

Riley Hospital for Children, Indianapolis

60201

NorthShore University Health System, Evanston

63110

Washington University Medical Center, St Louis

65212

University of Missouri-Columbia, Columbia

68506

St. Elizabeth Regional Medical Center, Lincoln

77030

Texas Children's Hospital, Houston

80045

Children's Hospital for Cancer & Blood Disorders, Aurora

84112

Huntsman Cancer Center, Salt Lake City

85016

Phoenix Children's Hospital, Phoenix

90017

Good Samaritan Hospital, Los Angeles

90027

Children's Hospital of Los Angeles, Los Angeles

92868

Children's Hospital of Orange County, Los Angeles

94115

California Pacific Medical Center, San Francisco

94609

Oakland's Children's Hospital, Oakland

98105

Children's Hospital and Regional Medical Center, Seattle

94304-1812

Stanford University Medical Center & Lucile Packard Children's Hospital, Palo Alto

04655

University of Massachusetts - Umass Memorial Medical Center, Worcester

07601

Hackensack University Medical Center, Hackensack

Sponsors
All Listed Sponsors
lead

BTG International Inc.

OTHER